2017
DOI: 10.1097/rli.0000000000000398
|View full text |Cite
|
Sign up to set email alerts
|

Magnetic Resonance Lymphography at 9.4 T Using a Gadolinium-Based Nanoparticle in Rats

Abstract: This study demonstrates that AGuIX is a suitable contrast agent for preclinical interstitial MRL in rodents. AGuIX yields anatomical imaging of lymphatic vessels with diameters greater than 200 μm. Moreover, it resides in the lymphatic system for a prolonged time. AGuIX may therefore facilitate high-resolution MRL-based analyses of the lymphatic system in rodents.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 43 publications
0
17
0
Order By: Relevance
“…Imaging was performed with a three-dimensional time of flight gradient recalled echo sequence (3D-TOF-GRE) originally adapted for imaging of peripheral lymph vessels [41] with recovery time of 12.0 ms, echo time of 2.5 ms, flip angle 25 o , matrix 600 × 400 × 180, field of view 36.00 mm × 25.92 mm × 18.00 mm, zero fill 2, 1 average and a scan time of 4 min 19 s 200 ms. Signal intensity (SI) reduction in blood vessels was achieved by placement of a saturation slice over the mouse heart.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Imaging was performed with a three-dimensional time of flight gradient recalled echo sequence (3D-TOF-GRE) originally adapted for imaging of peripheral lymph vessels [41] with recovery time of 12.0 ms, echo time of 2.5 ms, flip angle 25 o , matrix 600 × 400 × 180, field of view 36.00 mm × 25.92 mm × 18.00 mm, zero fill 2, 1 average and a scan time of 4 min 19 s 200 ms. Signal intensity (SI) reduction in blood vessels was achieved by placement of a saturation slice over the mouse heart.…”
Section: Methodsmentioning
confidence: 99%
“…Animals were examined in a horizontal-bore 9.4 T animal scanner (BioSpec Avance III 94/20; Bruker Biospin GmbH, Ettlingen, Germany) with a BGA12S gradient system with ParaVision 6.0.1 (Bruker Biospin GmbH) and a linearly polarized coil with an inner diameter of 40 mm (Bruker Biospin GmbH). Imaging was performed with a three-dimensional time of flight gradient recalled echo sequence (3D-TOF-GRE) originally adapted for imaging of peripheral lymph vessels [ 41 ] with recovery time of 12.0 ms, echo time of 2.5 ms, flip angle 25 o , matrix 600 × 400 × 180, field of view 36.00 mm × 25.92 mm × 18.00 mm, zero fill 2, 1 average and a scan time of 4 min 19 s 200 ms. Signal intensity (SI) reduction in blood vessels was achieved by placement of a saturation slice over the mouse heart.…”
Section: Methodsmentioning
confidence: 99%
“…A four–element receive–only cryogenic phased array coil (Bruker BioSpin GmbH) was used in combination with a linearly polarized room temperature volume resonator for transmission. Imaging was performed with a three-dimensional time of flight gradient recalled echo sequence (3D-TOF-GRE) 48 with an echo time/repetition time = 2.5/12.0 ms, flip angle 25°, matrix 480 × 360 × 180, field of view 36 mm × 27 mm × 18 mm, zero fill 2, 1 average and a scan time of 3 min 46 s. Both horizontal (dorsal to ventral) and sagittal (rostral to caudal) sections were scanned at t = 15 min, 25 min, 35 min, 45 min, 55 min after Gadospin D infusion. Signal intensity (SI) reduction in blood vessels was achieved by placement of a saturation slice over the mouse heart.…”
Section: Methodsmentioning
confidence: 99%
“…administration, and they can be further tuned towards lymph node accumulation (Schudel, Francis, & Thomas, 2019). This nanoparticle‐based lymphatic imaging has been used to monitor the impact of disease upon the lymphatic system, as well as identify sentinel lymph nodes in cancer (Müller et al, 2017; Taruno et al, 2019). As discussed previously in this review, nanoparticles also have a tendency to be taken up by immune cells, and therefore it is not surprising that nanotechnology‐based imaging agents are in development for imaging inflammation associated with disease states.…”
Section: Future Directionsmentioning
confidence: 99%